BioCryst Pharmaceuticals, Inc. (BCRX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about BioCryst Pharmaceuticals, Inc. (BCRX)
Go deeper and ask any question about BCRX
Company Performance
Current Price
as of Sep 13, 2024$7.92
P/E Ratio
N/A
Market Cap
$1.64B
Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Metrics
Overview
- HQDurham, NC
- SectorHealth Technology
- IndustryBiotechnology
- TickerBCRX
- Price$7.92+2.19%
Trading Information
- Market Cap$1.64B
- Float94.63%
- Average Daily Volume (1m)1,716,191
- Average Daily Volume (3m)2,644,347
- EPS-$0.73
Company
- Revenue$382.24M
- Rev Growth (1yr)32.54%
- Net Income-$12.67M
- Gross Margin98.12%
- EBITDA Margin8.31%
- EBITDA$9.08M
- EV$1.85B
- EV/Revenue4.85
- P/EN/A
- P/S4.28
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset